1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Voice of Customer
4.
Executive Summary
4.1. Overview of the Market
4.2. Overview of Key Market Segmentations
4.3. Overview of Key Market Players
4.4. Overview of Key Regions/Countries
4.5. Overview of Market Drivers, Challenges, Trends
5. Global gRNA Market Outlook
5.1.
Market Size &
Forecast
5.1.1.
By Value
5.2.
Market Share &
Forecast
5.2.1. By Type
(Research-Use, GMP-grade)
5.2.2. By Product &
Services (Products (gRNA Final Products, gRNA Synthesis Products, gRNA
Synthesis Kits, Plasmids, Others)), Custom gRNA Synthesis Services)
5.2.3. By Application
(Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics,
Others)
5.2.4. By End-Use
(Pharmaceutical & Biotechnology Companies, Academic Research Institutes,
CMOs & CROs)
5.2.5. By Region
5.2.6.
By Company (2023)
5.3.
Market Map
5.3.1.
By Type
5.3.2.
By Product &
Services
5.3.3.
By Application
5.3.4.
By End-Use
5.3.5.
By Region
6. Asia Pacific gRNA Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Type
6.2.2.
By Product &
Services
6.2.3.
By Application
6.2.4.
By End-Use
6.2.5.
By Country
6.3.
Asia Pacific:
Country Analysis
6.3.1.
China gRNA Market
Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Product &
Services
6.3.1.2.3.
By Application
6.3.1.2.4.
By End-Use
6.3.2.
India gRNA Market
Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Product &
Services
6.3.2.2.3.
By Application
6.3.2.2.4.
By End-Use
6.3.3.
Australia gRNA
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Product &
Services
6.3.3.2.3.
By Application
6.3.3.2.4.
By End-Use
6.3.4.
Japan gRNA Market
Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Type
6.3.4.2.2.
By Product &
Services
6.3.4.2.3.
By Application
6.3.4.2.4.
By End-Use
6.3.5.
South Korea gRNA
Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Type
6.3.5.2.2.
By Product &
Services
6.3.5.2.3.
By Application
6.3.5.2.4.
By End-Use
7. Europe gRNA Market Outlook
7.1.
Market Size &
Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type
7.2.2.
By Product &
Services
7.2.3.
By Application
7.2.4.
By End-Use
7.2.5.
By Country
7.3.
Europe: Country
Analysis
7.3.1.
France gRNA Market
Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Product &
Services
7.3.1.2.3.
By Application
7.3.1.2.4.
By End-Use
7.3.2.
Germany gRNA Market
Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Product &
Services
7.3.2.2.3.
By Application
7.3.2.2.4.
By End-Use
7.3.3.
Spain gRNA Market
Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Product &
Services
7.3.3.2.3.
By Application
7.3.3.2.4.
By End-Use
7.3.4.
Italy gRNA Market
Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Product &
Services
7.3.4.2.3.
By Application
7.3.4.2.4.
By End-Use
7.3.5.
United Kingdom gRNA
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Product &
Services
7.3.5.2.3.
By Application
7.3.5.2.4.
By End-Use
8. North America gRNA Market Outlook
8.1.
Market Size &
Forecast
8.1.1.
By Value
8.2.
Market Share &
Forecast
8.2.1.
By Type
8.2.2.
By Product &
Services
8.2.3.
By Application
8.2.4.
By End-Use
8.2.5.
By Country
8.3.
North America:
Country Analysis
8.3.1.
United States gRNA
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Product &
Services
8.3.1.2.3.
By Application
8.3.1.2.4.
By End-Use
8.3.2.
Mexico gRNA Market
Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Product &
Services
8.3.2.2.3.
By Application
8.3.2.2.4.
By End-Use
8.3.3.
Canada gRNA Market
Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Product &
Services
8.3.3.2.3.
By Application
8.3.3.2.4.
By End-Use
9. South America gRNA Market Outlook
9.1.
Market Size &
Forecast
9.1.1.
By Value
9.2.
Market Share &
Forecast
9.2.1. By Type
9.2.2. By Product &
Services
9.2.3. By Application
9.2.4. By End-Use
9.2.5.
By Country
9.3.
South America:
Country Analysis
9.3.1.
Brazil gRNA Market
Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Product &
Services
9.3.1.2.3.
By Application
9.3.1.2.4.
By End-Use
9.3.2.
Argentina gRNA
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Product &
Services
9.3.2.2.3.
By Application
9.3.2.2.4.
By End-Use
9.3.3.
Colombia gRNA Market
Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Product &
Services
9.3.3.2.3.
By Application
9.3.3.2.4.
By End-Use
10. Middle East and Africa gRNA Market Outlook
10.1.
Market Size &
Forecast
10.1.1.
By Value
10.2.
Market Share &
Forecast
10.2.1. By Type
10.2.2. By Product & Services
10.2.3. By Application
10.2.4. By End-Use
10.2.5. By Country
10.3.
MEA: Country
Analysis
10.3.1.
South Africa gRNA
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Product &
Services
10.3.1.2.3.
By Application
10.3.1.2.4.
By End-Use
10.3.2.
Saudi Arabia gRNA
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Product &
Services
10.3.2.2.3.
By Application
10.3.2.2.4.
By End-Use
10.3.3.
UAE gRNA Market
Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Product &
Services
10.3.3.2.3.
By Application
10.3.3.2.4.
By End-Use
10.3.4.
Egypt gRNA Market
Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Type
10.3.4.2.2.
By Product &
Services
10.3.4.2.3.
By Application
10.3.4.2.4.
By End-Use
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends &
Developments
12.1.
Recent Developments
12.2.
Product Launches (If Any)
12.3.
Mergers &
Acquisitions (If Any)
13.
Global gRNA Market:
SWOT Analysis
14. Porter’s Five Forces Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Products
15.
Competitive
Landscape
15.1.
Thermo Fisher Scientific, Inc.
15.1.1.
Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products &
Services
15.1.4.
Financials (In case
of listed)
15.1.5.
Recent Developments
15.1.6.
SWOT Analysis
15.2.
Agilent
Technologies, Inc.
15.3.
System Biosciences,
LLC
15.4.
Jena Bioscience GmbH
15.5.
Merck KGaA
15.6.
Azenta Us, Inc.
15.7.
Takara Bio, Inc.
15.8.
Synbio Technologies
15.9.
Revvity, Inc.
15.10.Synthego Corporation
16.
Strategic Recommendations
17. About Us & Disclaimer